Sana Biotechnology
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sana Biotechnology generated cash of -$253,582,000, which is more than the previous year. Cash used in financing activities reached the amount of $31,646,000 last year. Net change in cash is therefore -$49,924,000.
Cash Flow
| 2019 | -85.50M | -87.86M | 223.72M |
|---|---|---|---|
| 2020 | -137.98M | -252.56M | 435.68M |
| 2021 | -251.05M | -245.79M | 631.75M |
| 2022 | -290.05M | 210.56M | 4.91M |
| 2023 | -253.58M | 172.01M | 31.64M |
SANA Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 187.27M | 261.84M | 126.94M | 81.80M | 31.44M |
Operating activities | |||||
Net income | -283.25M | -269.47M | -355.92M | -285.30M | -130.77M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 24.55M | 15.62M | 11.07M | 5.92M | 1.82M |
Stock-based compensation expense | 35.53M | 38.33M | 22.36M | 5.82M | 1.49M |
| Deferred income tax benefit | 35.53M | 38.33M | 22.36M | 5.82M | 1.49M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 1.02M | 1.05M | -266K | 1.98M | -421K |
Cash generated by operating activities | -253.58M | -290.05M | -251.05M | -137.98M | -85.50M |
Investing activities | |||||
Purchases Of Investments | -157.74M | -78.68M | -491.38M | -387.43M | -141.51M |
Investments In Property Plant And Equipment | -20.03M | -20.87M | -29.86M | -23.87M | -26.18M |
Acquisitions Net | -192.04K | -231.43K | 0 | 228.69K | -3.19M |
Cash generated by investing activities | 172.01M | 210.56M | -245.79M | -252.56M | -87.86M |
Financing activities | |||||
Common Stock Issued | 31.64M | 4.91M | 631.75M | 149K | 1K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 31.64M | 4.91M | 631.75M | 435.68M | 223.72M |
Net Change In Cash | -49.92M | -74.57M | 134.89M | 45.14M | 50.36M |
Cash at end of period | 137.34M | 187.27M | 261.84M | 126.94M | 81.80M |
| Data source | Data source | Data source |